Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 299-304

  Ludwig, H C ^a   Feiz Erfan, I ^a   Bockermann, V ^a   Behnke Mursch, J ^a   Schallock, K ^a   Markakis, E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Glioblastoma; NOS expression; Oedema induction

Indexed keywords

CELL MARKER; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; EDEMA; ENDOTHELIUM CELL; ENZYME INDUCTION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR VOLUME;

ANTIBODIES, MONOCLONAL; AUTOANTIGENS; BRAIN EDEMA; BRAIN NEOPLASMS; DEXAMETHASONE; ENDOTHELIAL GROWTH FACTORS; ENZYME INDUCTION; EPIDERMAL GROWTH FACTOR; FEMALE; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION; ISOENZYMES; LYMPHOKINES; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SECOND MESSENGER SYSTEMS; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0034028131     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Snyder SH: Nitric oxide and neurons. Curr Opinion Neurobiol 2: 323-327, 1992.
2. Pollock JS, Forstermann U, Tracey WR and Nakane M: Nitric oxide synthase isozytnes antibodies. Histochem J 27: 738-744, 1995.
3. Norris PJ, Charles IG, Scorer CA and Emson PC: Studies on the localization and expression of nitric oxide synthase using histochemical techniques. Histochem J 27: 745-756, 1995.
4. Zhang ZG, Chopp M, Zaloga C, Pollock JS and Forstermann U: Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke 24: 2016-2022, 1993.
5. Brenman JE, Xia H, Chao DS, Black SM and Bredt DS: Regulation of neuronal nitric oxide synthase through alternative transcripts. Dev Neurosci 19: 224-231, 1997.
6. Plate KH, Breier G, Weich HA and Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomasi in vivo. Nature 359: 845-848, 1992.
7. Plate KH, Breier G, Weich HA, Mennel HD and Risau W: Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529, 1994.
8. Plate KH, Breier G, Weich HA and Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4: 207-218, 1994.
9. Cobbs CS, Brenman JE, Aldape KD, Bredt DS and Israel MA: Expression of nitric oxide synthase in human central nervous system Tumors. Cancer Res 55: 727-730, 1995.
10. Whittle IR, Collins F, Kelly PA, Ritchie I and Ironside JW: Nitric oxide synthase is expressed in experimental malignant glioma and influences tumour blood flow. Acta Neurochir Wien 138: 870-875, 1996.
11. Haregewoin A, Alexander E, Black PM and Loeffler JS: Autocrine regulation of the production of a gaseous messenger nitric oxide in a glioblastoma cell line. Exp Cell Res 210: 137-139, 1994.
12. Iwata S, Nakagawa K, Harada H, Oka Y, Kuman Y and Sakaki S: Endothelial nitric oxide synthase expression in tumor vasculature is correlated with malignancy in human supratentorial astrocytic tumors. Neurosurgery 45: 24-29, 1999.
13. Tozer GM, Prise VE and Chaplin DJ: Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 57: 948-955, 1997.
14. Paulus W, Roggendorf W and Kirchner T: Ki-M1 P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol Berl 84: 538-544, 1992.
15. Holscher Ch: Nitric oxide, the enigmatic neuronal messenger:its role in synaptic plasticity. TINS 20: 298-303, 1997.
16. Park SK and Murphy S: Duration of expression of inducible nitric oxide synthase in glial cells. J Neurosci Res 39: 405-411, 1994.
17. Simmons ML and Murphy S: Induction of nitric oxide synthase in glial cells. J Neurochem 59: 897-905, 1992.
18. Simmons ML and Murphy S: Cytokines regulate L-arginine-dependent cyclic GMP production in rat glial cells. Eur J Neurosci 5: 825-831, 1993.
19. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T and Isner JM: Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 3: 879-886, 1997.
20. Barna M, Komatsu T and Reiss CS: Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223: 331-343, 1996.
21. Hurst RD and Fritz IB: Nitric oxide-induced perturbations in a cell culture model of the blood-brain barrier. J Cell Physiol 167: 89-94, 1996.
22. Kourembanas S, Morita T, Liu Y and Christou H: Mechanisms by witch oxygen regulates gene expression and cell-cell interaction in the vasculature. Kidney Int 51: 438-443, 1997.
23. Nakano S, Matsukado K and Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56: 4027-4031, 1996.
24. Ijichi A, Sakuma S and Tofilon PJ: Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 14: 87-93, 1995.
25. Zhang S and Trussell LO: Voltage clamp analysis of excitatory synaptic transmission in the avian nucleus magnocellularis. J Physiol Lond 480: 123-136, 1994.
26. Ahmed A, Dunk C, Kniss D and Wilkes M: Role of VEGF receptor-I (FLT-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells. Lab Invest 76: 779-791, 1997.
27. Feinstein DL, Galea E, Cerrnak J, Chugh P, Lyandvert L and Reis DJ: Nitric oxide synthase expression in glial cells: suppression by tyrosine kinase inhibitors. J Neurochem 62: 811-814, 1994.
28. Galea E, Reddi J and Feinstein DL: Differential suppression of glial nitric oxide synthase induction by structurally related tyrosine kinase inhibitors. Neuroscience Letters 200: 195-198, 1995.
29. Hatva E, Kaipainen A, Jaaskelainen J, Paetau A, Haltia M and Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146: 368-378, 1995.
30. Roggendorf W, Strupp S and Paulus W: Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol Berl 92: 288-293, 1996.
31. Vodovotz Y and Bogdan Ch. Control of nitric oxide synthase expression by transforming growth factor-ß: implications for homeostasis. Progress in Growth Factor Research 5: 341-351, 1994.
32. Shoshan Y and Siegal T: Control of vasogenic edema in a brain tumor model: comparison between dexamethasone and superoxide dismutase. Neurosurgery 39: 1206-1214, 1996.
33. Wu HM, Huang Q, Yuan Y and Granger HJ: VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271: H2735-9, 1996.
34. Ziehe M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ and Bicknell R: Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99: 2625-2634, 1997.